646 filings
Page 3 of 33
8-K/A
0fk m4067sxuoh
16 May 23
Abbreviated Financial Statements
4:15pm
8-K
ft0y 0d8kxekb
4 May 23
Xtant Medical Announces First Quarter 2023 Revenue Growth of 38% and Full Year 2023 Revenue Guidance
7:15am
8-K
npglamcb56rpw
4 May 23
Departure of Directors or Certain Officers
7:10am
8-K
870z ma4do8amulrwx
7 Mar 23
Xtant Medical Announces Fourth Quarter and Full Year 2022 Financial Results
7:15am
8-K
vlc6menkjb
1 Mar 23
Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million
4:15pm
8-K
18lojs xngyc9wp7go07
1 Feb 23
Other Events
9:00am
8-K
7xg2rnhk6ussn2z
9 Jan 23
Xtant Medical Appoints Mark Schallenberger as Chief Operations Officer
8:15am
8-K
l1dpho5hb2t6nvu9
3 Nov 22
Xtant Medical Announces Third Quarter 2022 Financial Results
7:05am
S-8
ssuy82e
28 Oct 22
Registration of securities for employees
4:26pm
8-K
oybyuy18xtu hb
28 Oct 22
Departure of Directors or Certain Officers
4:15pm
EFFECT
fra9i2iy b1cx
21 Oct 22
Notice of effectiveness
12:15am
424B3
ej9s8o88w0
20 Oct 22
Prospectus supplement
5:24pm
CORRESP
lvca8a hnyo
18 Oct 22
Correspondence with SEC
12:00am
UPLOAD
ocbxco3w5
17 Oct 22
Letter from SEC
12:00am
8-K
d2ntyo
11 Oct 22
Xtant Medical Announces Closing of Second Tranche of $9.75 Million Private Investment
8:15am